Sun Pharma and Dr Reddy’s Lab were among the key index losers that led to the Nifty slipping in early trade.Other pharma ...

Stocks in the Nifty Pharma index were down by as much as 6% following US President Donald Trump's proposal to impose tariffs; ...

The decline in pharma stocks followed comments from President Donald Trump, who indicated that the US may impose tariffs of ...

Editor-in-chief Nikunj Dalmia on Wednesday (Feb 19) said that there are two factors which are at play for the market now and ...

India currently imposes a 10% tariff on medicines imported from US. If Donald Trump decides to increase the tariff on Indian ...

The Nifty Pharma index was the hardest hit among sectoral indices, dropping over 2 percent after Trump announced plans to ...

Shares of Indian pharmaceutical companies slid 2.2% on Wednesday after U.S. President Donald Trump said he intends to impose ...

In the face of looming revenue decline from blood cancer medication Revlimid, Indian pharma companies Natco Pharma and Dr.

After President Donald Trump’s November 2024 election victory, the Financial Times had reported $140 billion new investment into US equity funds in just the first month. While there is certainly cause ...

Discover Nova Measurements' impressive growth, rising shares, and strong future projections. Explore key factors driving ...

The National Pharmaceutical Pricing Authority (NPPA) has directed all drug manufacturers and marketers to reduce the Maximum ...

Growth stocks outpaced their value counterparts during the quarter, even as some investors sought lower-volatility positions.